Radiologic response to MEK inhibition in a patient with a WNT‐activated craniopharyngioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Radiologic response to MEK inhibition in a patient with a WNT‐activated craniopharyngioma

Published:2020-10-19 Issue:3 Volume:68 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Patel Krupesh¹^ORCID,Allen Jeffrey¹,Zagzag David²,Wisoff Jeffrey³,Radmanesh Alireza⁴,Gindin Tatyana²,Nicolaides Theodore¹

Affiliation:

1. Department of Pediatrics NYU Langone Health New York New York

2. Department of Pathology NYU Langone Health New York New York

3. Department of Neurosurgery NYU Langone Health New York New York

4. Department of Radiology NYU Langone Health New York New York

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28753

Reference9 articles.

1. Novel activating KRAS mutation candidates in lung adenocarcinoma

2. Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target

3. Explore MAPK Cancer Pathway | BioOncology.Biooncology www.biooncology.com/pathways/cancer-tumor-targets/mapk.html. Accessed 17 Apr 2020.

4. Craniopharyngioma

5. Adamantinomatous craniopharyngioma: moving toward targeted therapies;Hengartner AC;Neurosurg Focus,2020

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progression;Acta Neuropathologica Communications;2024-08-10

2. Molecular Developments in Parasellar Tumors and Potential Therapeutic Implications;Endocrine Reviews;2024-07-26

3. Approach to the Patient: New Era Emerges for Craniopharyngioma Management;The Journal of Clinical Endocrinology & Metabolism;2024-07-23

4. Integrating Systemic Therapies into the Multimodality Therapy of Patients with Craniopharyngioma;Current Treatment Options in Oncology;2024-02

5. Advancing Craniopharyngioma Management: A Systematic Review of Current Targeted Therapies and Future Perspectives;International Journal of Molecular Sciences;2024-01-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3